Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: Eterna Therapeutics (NASDAQ:ERNA), CERo Therapeutics Hldgs (NASDAQ:CERO), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP) and Imunon (NASDAQ:IMNN).
Mainz Biomed has a consensus price target of $11.00.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $6.9 last updated December 20, 2024 at 7:55 PM EST.
There are no upcoming dividends for Mainz Biomed.
Mainz Biomed’s H1 earnings are confirmed for Monday, October 21, 2024.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.